These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 18327554)

  • 1. Post-translational modifications of recombinant proteins: significance for biopharmaceuticals.
    Jenkins N; Murphy L; Tyther R
    Mol Biotechnol; 2008 Jun; 39(2):113-8. PubMed ID: 18327554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications of therapeutic proteins: challenges and prospects.
    Jenkins N
    Cytotechnology; 2007 Apr; 53(1-3):121-5. PubMed ID: 19003198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant protein expression: Challenges in production and folding related matters.
    Beygmoradi A; Homaei A; Hemmati R; Fernandes P
    Int J Biol Macromol; 2023 Apr; 233():123407. PubMed ID: 36708896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility of protein therapeutics to spontaneous chemical modifications by oxidation, cyclization, and elimination reactions.
    Grassi L; Cabrele C
    Amino Acids; 2019 Nov; 51(10-12):1409-1431. PubMed ID: 31576455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sweet tooth of biopharmaceuticals: importance of recombinant protein glycosylation analysis.
    Lingg N; Zhang P; Song Z; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1462-72. PubMed ID: 22829536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current achievements in the production of complex biopharmaceuticals with moss bioreactors.
    Decker EL; Reski R
    Bioprocess Biosyst Eng; 2008 Jan; 31(1):3-9. PubMed ID: 17701058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimizing immunogenicity of biopharmaceuticals by controlling critical quality attributes of proteins.
    van Beers MM; Bardor M
    Biotechnol J; 2012 Dec; 7(12):1473-84. PubMed ID: 23027660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for analysing and improving the expression and quality of recombinant proteins made in mammalian cells.
    Jenkins N; Meleady P; Tyther R; Murphy L
    Biotechnol Appl Biochem; 2009 May; 53(Pt 2):73-83. PubMed ID: 19397493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast synthetic biology for the production of recombinant therapeutic proteins.
    Kim H; Yoo SJ; Kang HA
    FEMS Yeast Res; 2015 Feb; 15(1):1-16. PubMed ID: 25130199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The significance of glycosylation analysis in development of biopharmaceuticals.
    Kawasaki N; Itoh S; Hashii N; Takakura D; Qin Y; Huang X; Yamaguchi T
    Biol Pharm Bull; 2009 May; 32(5):796-800. PubMed ID: 19420744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biopharmaceuticals from plants: a multitude of options for posttranslational modifications.
    Warzecha H
    Biotechnol Genet Eng Rev; 2008; 25():315-30. PubMed ID: 21412360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous monitoring of oxidation, deamidation, isomerization, and glycosylation of monoclonal antibodies by liquid chromatography-mass spectrometry method with ultrafast tryptic digestion.
    Wang Y; Li X; Liu YH; Richardson D; Li H; Shameem M; Yang X
    MAbs; 2016; 8(8):1477-1486. PubMed ID: 27598507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique Impacts of Methionine Oxidation, Tryptophan Oxidation, and Asparagine Deamidation on Antibody Stability and Aggregation.
    Alam ME; Slaney TR; Wu L; Das TK; Kar S; Barnett GV; Leone A; Tessier PM
    J Pharm Sci; 2020 Jan; 109(1):656-669. PubMed ID: 31678251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications of recombinant monoclonal antibodies in vivo.
    Liu H; Nowak C; Patel R
    Biologicals; 2019 May; 59():1-5. PubMed ID: 30910309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Separation of post-translational modifications in monoclonal antibodies by exploiting subtle conformational changes under mildly acidic conditions.
    Wang S; Ionescu R; Peekhaus N; Leung JY; Ha S; Vlasak J
    J Chromatogr A; 2010 Oct; 1217(42):6496-502. PubMed ID: 20828701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Targeting for Precision Glyco-Engineering: Production of Biopharmaceuticals Devoid of Plant-Typical Glycosylation in Moss Bioreactors.
    Decker EL; Wiedemann G; Reski R
    Methods Mol Biol; 2015; 1321():213-24. PubMed ID: 26082225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein folding and modification in the mammalian endoplasmic reticulum.
    Braakman I; Bulleid NJ
    Annu Rev Biochem; 2011; 80():71-99. PubMed ID: 21495850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemical Characterization of Human Anti-Hepatitis B Monoclonal Antibody Produced in the Microalgae Phaeodactylum tricornutum.
    Vanier G; Hempel F; Chan P; Rodamer M; Vaudry D; Maier UG; Lerouge P; Bardor M
    PLoS One; 2015; 10(10):e0139282. PubMed ID: 26437211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cetuximab Fab and Fc N-glycan fast characterization using IdeS digestion and liquid chromatography coupled to electrospray ionization mass spectrometry.
    Janin-Bussat MC; Tonini L; Huillet C; Colas O; Klinguer-Hamour C; Corvaïa N; Beck A
    Methods Mol Biol; 2013; 988():93-113. PubMed ID: 23475716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspectives for Glyco-Engineering of Recombinant Biopharmaceuticals from Microalgae.
    Barolo L; Abbriano RM; Commault AS; George J; Kahlke T; Fabris M; Padula MP; Lopez A; Ralph PJ; Pernice M
    Cells; 2020 Mar; 9(3):. PubMed ID: 32151094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.